Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-11-20
pubmed:abstractText
Heme oxygenase-1 (HO-1; encoded by the Hmox1 gene) catalyzes the degradation of free heme into biliverdin, via a reaction that releases iron (Fe) and carbon monoxide. We report that HO-1 down-regulates the proinflammatory phenotype associated with endothelial cell (EC) activation by reducing intracellular nonprotein-bound Fe (labile Fe). EC isolated from Hmox1(-/-) mice have higher levels of intracellular labile Fe and reactive oxygen species (ROS) as compared with EC isolated from Hmox1(+/+) mice. Basal and TNF-induced expression of VCAM-1, ICAM-1, and E-selectin were increased in Hmox1(-/-) vs Hmox1(+/+) EC, an effect reversed by Fe chelation using deferoxamine mesylate (DFO). Fe chelation inhibits TNF-driven transcription of Vcam-1, Icam-1, and E-selectin, as assessed using luciferase reporter assays. This effect is associated with inhibition of the transcription factor NF-kappaB via a mechanism that is not associated with the inhibition of IkappaBalpha phosphorylation/degradation or NF-kappaB (i.e., RelA) nuclear translocation, although it affects very modestly NF-kappaB binding to DNA kappaB consensus sequences in the Vcam-1 and E-selectin promoters. HO-1 inhibits NF-kappaB (i.e., RelA) phosphorylation at Ser(276), a phosphoacceptor that is critical to sustain TNF-driven NF-kappaB activity in EC. This effect was mimicked by Fe chelation as well as by antioxidants (N-acetylcysteine). In conclusion, we demonstrate a novel mechanism via which HO-1 down-modulates the proinflammatory phenotype of activated EC, i.e., the inhibition of RelA phosphorylation at Ser(276).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
179
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7840-51
pubmed:meshHeading
pubmed-meshheading:18025230-Animals, pubmed-meshheading:18025230-Cell Adhesion Molecules, pubmed-meshheading:18025230-Cells, Cultured, pubmed-meshheading:18025230-Down-Regulation, pubmed-meshheading:18025230-Endothelial Cells, pubmed-meshheading:18025230-Ferric Compounds, pubmed-meshheading:18025230-Gene Expression Regulation, pubmed-meshheading:18025230-Heme Oxygenase-1, pubmed-meshheading:18025230-Inflammation, pubmed-meshheading:18025230-Mice, pubmed-meshheading:18025230-Mice, Inbred BALB C, pubmed-meshheading:18025230-Mice, Knockout, pubmed-meshheading:18025230-NF-kappa B, pubmed-meshheading:18025230-Phosphorylation, pubmed-meshheading:18025230-Serine, pubmed-meshheading:18025230-Transcription, Genetic, pubmed-meshheading:18025230-Transcription Factor RelA, pubmed-meshheading:18025230-Vascular Cell Adhesion Molecule-1
pubmed:year
2007
pubmed:articleTitle
Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276.
pubmed:affiliation
Instituto Gulbenkian de Ciência, Apartado 14, Oeiras, Portugal.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't